State Stem Cell Agency ICOC Legislative Subcommittee Agenda 4/27/09

Apr 27, 2009
Main Location: 

CIRM
210 King Street
San Francisco, CA 94107

Additional Locations: 
136 Roanoke Street San Francisco, CA 94131
Klein Financial Corporation 550 California Avenue Palo Alto, CA 94306
MDV-Mohr Davidow Ventures 3000 Sand Hill Road, Bldg 3, Ste 290 Menlo Park, CA 94025
CONNECT 8950 Villa La Jolla Drive Suite A124 La Jolla, CA 92037
2476 Lancelot Lane Los Angeles, CA 90077
330 Plaza Street Healdsburg, CA 95448
8170 Laguna Blvd., #215 Elk Grove, CA 95758
UC Davis School of Medicine Education Building 4610 X Street Conference Room 4202C
11 Buck Meadow Drive Portola Valley, CA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

 
MEETING NOTICE AND AGENDA

LEGISLATIVE SUBCOMMITTEE OF THE INDEPENDENT CITIZENS' OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM) 

Organized Pursuant To Government Code section 11346.5(a)(17)
and

The CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

Date: Monday, April 27, 2009
 

Time:   7:30 a.m. to 8:30 a.m. PST

Location:

  • CIRM
    210 King Street
    San Francisco, CA 94107
  • MDV-Mohr Davidow Ventures
    3000 Sand Hill Road,
    Bldg 3, Ste 290
    Menlo Park, CA 94025
  • 330 Plaza Street
    Healdsburg, CA 95448
  • 136 Roanoke Street
    San Francisco, CA 94131
  • CONNECT
    8950 Villa La Jolla Drive
    Suite A124
    La Jolla, CA 92037
  • 8170 Laguna Blvd., #215
    Elk Grove, CA 95758
  • 11 Buck Meadow Drive
    Portola Valley, CA
  • Klein Financial Corporation
    550 California Avenue
    Palo Alto, CA 94306
  • 2476 Lancelot Lane
    Los Angeles, CA 90077
  • UC Davis School of Medicine
    Education Building
    4610 X Street
    Conference Room 4202C

Open Session

  1. Call to Order 
  2. Roll Call

    [Members of the Public will be invited to provide testimony before or during consideration of each agenda item.  Speakers are asked to limit their testimony to three (3) minutes.]

  3. Consideration of federal legislation, H.R. 1427 and H.R. 1548.
    1. Side-by-side comparison of H.R. 1427 and H.R. 1548
  4. Consideration of comments on NIH draft guidelines for research utilizing human embryonic stem cells.
    1. Item 4 Attachment A
    2. Item 4 Attachment B
    3. Item 4 Attachment C
  5. Public Comment
  6. Adjournment

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

 

Transcripts: 

© 2013 California Institute for Regenerative Medicine